• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环磷酰胺和异环磷酰胺的人体代谢物和转化产物:分析、在非生物处理过程中的出现和形成。

Human metabolites and transformation products of cyclophosphamide and ifosfamide: analysis, occurrence and formation during abiotic treatments.

机构信息

Jožef Stefan Institute, Jamova cesta 39, 1000, Ljubljana, Slovenia.

Jožef Stefan International Postgraduate School, Jamova cesta 39, 1000, Ljubljana, Slovenia.

出版信息

Environ Sci Pollut Res Int. 2016 Jun;23(11):11209-11223. doi: 10.1007/s11356-016-6321-1. Epub 2016 Feb 27.

DOI:10.1007/s11356-016-6321-1
PMID:26920534
Abstract

This study describes a gas chromatography-mass spectrometry analytical method for the analysis of cytostatic cyclophosphamide (CP), ifosfamide (IF) and their selected metabolites/transformation products (TPs): carboxy-cyclophosphamide (carboxy-CP), keto-cyclophosphamide (keto-CP) and 3-dechloroethyl-ifosfamide/N-dechloroethyl-cyclophosphamide (N-decl-CP) in wastewater (WW). Keto-cyclophosphamide, CP and IF were extracted with Oasis HLB and N-decl-CP and carboxy-CP with Isolute ENV+ cartridges. Analyte derivatization was performed by silylation (metabolites/TPs) and acetylation (CP and IF). The recoveries and LOQs of the developed method were 58, 87 and 103 % and 77.7, 43.7 and 6.7 ng L(-1) for carboxy-CP, keto-CP and N-decl-CP, respectively. After validation, the analytical method was applied to hospital WW and influent and effluent samples of a receiving WW treatment plant. In hospital WW, levels up to 2690, 47.0, 13,200, 2100 and 178 ng L(-1) were detected for CP, IF, carboxy-CP, N-decl-CP and keto-CP, respectively, while in influent and effluent samples concentrations were below LOQs. The formation of TPs during abiotic treatments was also studied. Liquid chromatography-high-resolution mass spectrometry was used to identify CP and IF TPs in ultrapure water, treated with UV and UV/H2O2. UV treatment produced four CP TPs and four IF TPs, while UV/H2O2 resulted in five CPs and four IF TPs. Besides already known TPs, three novel TPs (CP-TP138a, imino-ifosfamide and IF-TP138) have been tentatively identified. In hospital WW treated by UV/O3/H2O2, none of the target metabolites/TPs resulted above LOQs.

摘要

本研究描述了一种用于分析细胞毒性环磷酰胺(CP)、异环磷酰胺(IF)及其选定代谢物/转化产物(TPs)的气相色谱-质谱分析方法:羧基-环磷酰胺(carboxy-CP)、酮-环磷酰胺(keto-CP)和 3-去氯乙基-异环磷酰胺/N-去氯乙基-环磷酰胺(N-decl-CP)在废水中(WW)。酮-环磷酰胺、CP 和 IF 用 Oasis HLB 提取,N-decl-CP 和 carboxy-CP 用 Isolute ENV+ 提取。通过硅烷化(代谢物/TPs)和乙酰化(CP 和 IF)对分析物进行衍生化。该方法的回收率和 LOQs 分别为 58%、87%和 103%,以及 77.7、43.7 和 6.7ng/L 用于 carboxy-CP、keto-CP 和 N-decl-CP。经过验证,该分析方法应用于医院 WW 以及接收 WW 处理厂的进水和出水样品。在医院 WW 中,检测到 CP、IF、carboxy-CP、N-decl-CP 和 keto-CP 的浓度分别高达 2690、47.0、13200、2100 和 178ng/L,而进水和出水样品的浓度均低于 LOQs。还研究了在非生物处理过程中 TPs 的形成。使用液相色谱-高分辨率质谱法在超纯水中鉴定 CP 和 IF 的 TPs,并用 UV 和 UV/H2O2 处理。UV 处理产生了四种 CP TPs 和四种 IF TPs,而 UV/H2O2 则产生了五种 CP 和四种 IF TPs。除了已知的 TPs 外,还初步鉴定了三种新型 TPs(CP-TP138a、亚氨基异环磷酰胺和 IF-TP138)。在经 UV/O3/H2O2 处理的医院 WW 中,没有一种目标代谢物/TPs 的浓度超过 LOQs。

相似文献

1
Human metabolites and transformation products of cyclophosphamide and ifosfamide: analysis, occurrence and formation during abiotic treatments.环磷酰胺和异环磷酰胺的人体代谢物和转化产物:分析、在非生物处理过程中的出现和形成。
Environ Sci Pollut Res Int. 2016 Jun;23(11):11209-11223. doi: 10.1007/s11356-016-6321-1. Epub 2016 Feb 27.
2
Evaluation of acute and chronic ecotoxicity of cyclophosphamide, ifosfamide, their metabolites/transformation products and UV treated samples.评价环磷酰胺、异环磷酰胺及其代谢物/转化产物和经紫外线处理样品的急性和慢性生态毒性。
Environ Pollut. 2018 Feb;233:356-363. doi: 10.1016/j.envpol.2017.10.066. Epub 2017 Nov 5.
3
Occurrence of cyclophosphamide and ifosfamide in aqueous environment and their removal by biological and abiotic wastewater treatment processes.环磷酰胺和异环磷酰胺在水环境中的出现及其通过生物和非生物废水处理工艺的去除。
Sci Total Environ. 2015 Sep 15;527-528:465-73. doi: 10.1016/j.scitotenv.2015.04.109. Epub 2015 May 14.
4
Photocatalytic degradation of cyclophosphamide and ifosfamide: Effects of wastewater matrix, transformation products and in silico toxicity prediction.光催化降解环磷酰胺和异环磷酰胺:废水基质、转化产物的影响及计算毒性预测。
Sci Total Environ. 2019 Nov 20;692:503-510. doi: 10.1016/j.scitotenv.2019.07.247. Epub 2019 Jul 17.
5
Ecotoxicity and genotoxicity of cyclophosphamide, ifosfamide, their metabolites/transformation products and their mixtures.环磷酰胺、异环磷酰胺及其代谢物/转化产物及其混合物的生态毒性和遗传毒性。
Environ Pollut. 2016 Mar;210:192-201. doi: 10.1016/j.envpol.2015.12.017. Epub 2015 Dec 29.
6
Estimation of the cancer risk to humans resulting from the presence of cyclophosphamide and ifosfamide in surface water.估算地表水存在的环磷酰胺和异环磷酰胺对人类的癌症风险。
Environ Sci Pollut Res Int. 2010 Feb;17(2):486-96. doi: 10.1007/s11356-009-0195-4. Epub 2009 Jun 24.
7
Determination of cyclophosphamide and ifosfamide in sewage effluent by stable isotope-dilution liquid chromatography-tandem mass spectrometry.采用稳定同位素稀释液相色谱-串联质谱法测定污水中的环磷酰胺和异环磷酰胺。
J Chromatogr A. 2011 Nov 25;1218(47):8519-28. doi: 10.1016/j.chroma.2011.09.061. Epub 2011 Sep 29.
8
Occurrence and fate of the cytostatic drugs cyclophosphamide and ifosfamide in wastewater and surface waters.细胞毒性药物环磷酰胺和异环磷酰胺在废水和地表水中的存在及归宿
Environ Sci Technol. 2006 Dec 1;40(23):7242-50. doi: 10.1021/es0609405.
9
Application of high performance liquid chromatography/tandem mass spectrometry in the environmental and biological monitoring of health care personnel occupationally exposed to cyclophosphamide and ifosfamide.高效液相色谱/串联质谱法在职业接触环磷酰胺和异环磷酰胺的医护人员环境与生物监测中的应用
Rapid Commun Mass Spectrom. 1998;12(20):1485-93. doi: 10.1002/(SICI)1097-0231(19981030)12:20<1485::AID-RCM333>3.0.CO;2-N.
10
Quantitation of anticancer drugs - Cyclophosphamide and ifosfamide in urine and water sewage samples by gas chromatography-mass spectrometry.气相色谱-质谱联用法定量分析尿液和污水样本中的抗癌药物——环磷酰胺和异环磷酰胺。
Int J Occup Med Environ Health. 2016;29(5):815-22. doi: 10.13075/ijomeh.1896.00773.

引用本文的文献

1
Influence of Puncture Devices on the Accuracy of Cyclophosphamide Dosing for Chemotherapy Administration.穿刺装置对化疗给药中 cyclophosphamide 剂量准确性的影响。
Pharmaceuticals (Basel). 2025 Jun 12;18(6):879. doi: 10.3390/ph18060879.
2
Occurrence of anticancer drugs in the aquatic environment: a systematic review.抗癌药物在水环境中的存在:系统评价。
Environ Sci Pollut Res Int. 2020 Jan;27(2):1339-1347. doi: 10.1007/s11356-019-07045-2. Epub 2019 Dec 12.
3
Insights into Mechanisms of Electrochemical Drug Degradation in Their Mixtures in the Split-Flow Reactor.

本文引用的文献

1
Ecotoxicity and genotoxicity of cyclophosphamide, ifosfamide, their metabolites/transformation products and their mixtures.环磷酰胺、异环磷酰胺及其代谢物/转化产物及其混合物的生态毒性和遗传毒性。
Environ Pollut. 2016 Mar;210:192-201. doi: 10.1016/j.envpol.2015.12.017. Epub 2015 Dec 29.
2
Occurrence of cyclophosphamide and ifosfamide in aqueous environment and their removal by biological and abiotic wastewater treatment processes.环磷酰胺和异环磷酰胺在水环境中的出现及其通过生物和非生物废水处理工艺的去除。
Sci Total Environ. 2015 Sep 15;527-528:465-73. doi: 10.1016/j.scitotenv.2015.04.109. Epub 2015 May 14.
3
Predicting concentrations of cytostatic drugs in sewage effluents and surface waters of Catalonia (NE Spain).
在分流反应器中电化学药物降解混合物的机制研究。
Molecules. 2019 Nov 28;24(23):4356. doi: 10.3390/molecules24234356.
4
The effects and the toxicity increases caused by bicarbonate, chloride, and other water components during the UV/TiO degradation of oxazaphosphorine drugs.在恶唑磷药物的紫外/二氧化钛降解过程中,碳酸氢盐、氯化物和其他水成分所引起的影响及毒性增加。
Environ Sci Pollut Res Int. 2017 Jun;24(17):14595-14604. doi: 10.1007/s11356-017-9005-6. Epub 2017 Apr 27.
5
p53 induction and cell viability modulation by genotoxic individual chemicals and mixtures.个体化学物和混合物的遗传毒性对 p53 的诱导和细胞活力的调节。
Environ Sci Pollut Res Int. 2018 Feb;25(5):4012-4022. doi: 10.1007/s11356-017-8790-2. Epub 2017 Mar 16.
6
Fate and effects of the residues of anticancer drugs in the environment.抗癌药物在环境中的残留命运及影响。
Environ Sci Pollut Res Int. 2016 Aug;23(15):14687-91. doi: 10.1007/s11356-016-7069-3. Epub 2016 Jun 28.
预测加泰罗尼亚(西班牙东北部)污水和地表水中细胞毒性药物的浓度。
Environ Res. 2015 Apr;138:161-72. doi: 10.1016/j.envres.2015.02.015. Epub 2015 Feb 23.
4
TiO2 photocatalytic degradation and transformation of oxazaphosphorine drugs in an aqueous environment.TiO2 光催化降解和转化水环境中的氧杂磷杂环类药物。
J Hazard Mater. 2015 Apr 28;287:133-41. doi: 10.1016/j.jhazmat.2015.01.045. Epub 2015 Jan 21.
5
Photodegradation of the antineoplastic cyclophosphamide: a comparative study of the efficiencies of UV/H2O2, UV/Fe2+/H2O2 and UV/TiO2 processes.抗肿瘤药物环磷酰胺的光降解:UV/H2O2、UV/Fe2+/H2O2和UV/TiO2工艺效率的比较研究
Chemosphere. 2015 Feb;120:538-46. doi: 10.1016/j.chemosphere.2014.08.076. Epub 2014 Oct 8.
6
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.全球癌症发病与死亡:GLOBOCAN 2012 数据源、方法与主要模式。
Int J Cancer. 2015 Mar 1;136(5):E359-86. doi: 10.1002/ijc.29210. Epub 2014 Oct 9.
7
Cytostatic drugs and metabolites in municipal and hospital wastewaters in Spain: filtration, occurrence, and environmental risk.西班牙城市和医院废水中的细胞抑制剂药物和代谢物:过滤、出现和环境风险。
Sci Total Environ. 2014 Nov 1;497-498:68-77. doi: 10.1016/j.scitotenv.2014.07.101. Epub 2014 Aug 12.
8
Removal of antineoplastic drugs cyclophosphamide, ifosfamide, and 5-fluorouracil and a vasodilator drug pentoxifylline from wastewaters by ozonation.通过臭氧氧化法去除废水中的抗肿瘤药物环磷酰胺、异环磷酰胺和5-氟尿嘧啶以及血管扩张剂药物己酮可可碱。
Environ Sci Pollut Res Int. 2015 Jan;22(1):508-15. doi: 10.1007/s11356-014-3288-7. Epub 2014 Aug 5.
9
Occurrence of cytostatic compounds in hospital effluents and wastewaters, determined by liquid chromatography coupled to high-resolution mass spectrometry.采用液相色谱-高分辨率质谱联用技术测定医院污水和废水中细胞抑制化合物的含量。
Anal Bioanal Chem. 2014 Jun;406(16):3801-14. doi: 10.1007/s00216-014-7805-9. Epub 2014 May 14.
10
Prevalence and sunlight photolysis of controlled and chemotherapeutic drugs in aqueous environments.控制药物和化疗药物在水环境中的流行程度和阳光光解作用。
Environ Pollut. 2014 Apr;187:170-81. doi: 10.1016/j.envpol.2014.01.005. Epub 2014 Feb 5.